Up until two years ago, using large language models was still considered a special skill that everyone was encouraged to ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel ...

The figure, which is much higher than previous estimates of Large Language Model use, is for papers published in December and ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 7, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery ...

Manchester researchers have developed a systematic methodology to test whether AI can think logically in biomedical research, helping to ensure safer, more reliable applications in health care ...

Generative artificial intelligence (AI) powered by human language has made remarkable progress and gained widespread use through tools such as ChatGPT. While it is mostly known for helping with ...

An analysis has shown that the landscape of AI (artificial intelligence) writing scientific papers is becoming normalized ...

JMIR Publications invites submissions to a new theme issue titled “AI Applications in Biomedical Engineering” in its open access journal JMIR Biomedical Engineering. AI is rapidly advancing biomedical ...

Researchers at Rochester Institute of Technology developed new artificial intelligence techniques to extract and visualize information from standard-of-care biomedical data, providing a means for ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and ...